|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||27.90 - 28.40|
|52-week range||25.00 - 33.00|
|Beta (5Y monthly)||0.49|
|PE ratio (TTM)||29.96|
|Forward dividend & yield||0.64 (2.28%)|
|Ex-dividend date||28 Apr 2022|
|1y target est||N/A|
LexisNexis® Risk Solutions and Capgemini Invent released findings from their inaugural LexisNexis® Risk Solutions Corporate Digital Payments Study. The organizations jointly conducted global market research on corporate account-to-account (A2A) payments with three objectives: 1) to evaluate the status of A2A payments for large multinational corporations; 2) to assess key priorities for payment executives to transform their payment function; and 3) to identify key trends that are reshaping the co
NEW YORK, May 18, 2022--Cirium, the aviation analytics company, partners with travel data analytics firm, 3Victors to enable airports and DMOs to forecast passenger demand.
The Health Care business of LexisNexis Risk Solutions has been named a 2022 MedTech Breakthrough Award recipient for its next-generation tokenization solution, LexisNexis® Gravitas™. As an independent market intelligence organization, MedTech Breakthrough recognizes the top companies, technologies, and products in the global health and medical technology market.